Relationship between lithium carbonate and the risk of Parkinson-like events in patients with bipolar disorders: A multivariate analysis using the Japanese adverse drug event report database

Psychiatry Res. 2022 Aug:314:114687. doi: 10.1016/j.psychres.2022.114687. Epub 2022 Jun 19.

Abstract

The present study attempted to identify risk factors for Parkinson-like events using the Japanese adverse drug event report database. A total of 3521 patients with bipolar disorders were extracted from the database, and Parkinson-like events were detected in 111 (3.15%) using the standardized Medical Dictionary for Regulatory Activities queries. A multiple logistic regression analysis identified age ≥50 years and the use of sodium valproate or aripiprazole as risk factors. Lithium carbonate was not associated with an increased risk of Parkinson-like events, but was related to these events in patients taking sodium valproate.

Keywords: Lithium carbonate; Parkinson-like events; Sodium valproate.

MeSH terms

  • Antimanic Agents / adverse effects
  • Bipolar Disorder* / chemically induced
  • Bipolar Disorder* / drug therapy
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Japan / epidemiology
  • Lithium / therapeutic use
  • Lithium Carbonate / adverse effects
  • Middle Aged
  • Multivariate Analysis
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / epidemiology
  • Valproic Acid / therapeutic use

Substances

  • Antimanic Agents
  • Lithium Carbonate
  • Valproic Acid
  • Lithium